Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines

Published:2017-02-07 Issue:5 Volume:39 Page:900-907
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Enzenhofer Elisabeth¹,Kadletz Lorenz¹,Stanisz Isabella¹,Kotowski Ulana¹,Seemann Rudolf²,Schmid Rainer³,Thurnher Dietmar¹⁴,Heiduschka Gregor¹

Affiliation:

1. Department of Otorhinolaryngology, Head and Neck Surgery; Medical University of Vienna; Vienna Austria

2. Department of Oral and Maxillofacial Surgery; Medical University of Vienna; Vienna Austria

3. Department of Radiotherapy; Medical University of Vienna; Vienna Austria

4. Department of Otorhinolaryngology; Head and Neck Surgery, Medical University of Graz; Graz Austria

Publisher

Wiley

Subject

Otorhinolaryngology

Reference43 articles.

1. Head and neck cancer;Argiris;Lancet,2008

2. The epigenomics of cancer;Jones;Cell,2007

3. An increasingly complex code;Spotswood;J Clin Invest,2002

4. Acetylation and deacetylation of non-histone proteins;Glozak;Gene,2005

5. Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma;Erlich;Br J Cancer,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic inhibitors and their role in cancer therapy;Epigenetic Regulation of Cancer - Part A;2023

2. Histone deacetylase inhibitor resminostat in combination with sorafenib counteracts platelet-mediated pro-tumoral effects in hepatocellular carcinoma;Scientific Reports;2021-05-05

3. Entinostat is a novel therapeutic agent to treat oral squamous cell carcinoma;Journal of Oral Pathology & Medicine;2020-06-11

4. Novel α,β-unsaturated hydroxamic acid derivatives overcome cisplatin resistance;Bioorganic & Medicinal Chemistry;2019-10

5. Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer;Frontiers in Pharmacology;2019-06-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3